Search results for Cetuximab

Cetuximab Biosimilar – Research Grade mAb, ProteoGenix, PX-TA1019-

Cetuximab, Affinityimmuno, ab-131-cetuximab

Cetuximab, Abbexa, abx831065

Cetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EGFR, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Cetuximab is marketed under the brand Erbitux® by Eli Lilly and Company. In the United States, a regimen of cetuximab costs approximately $30, 790 for an eight-week course. Cetuximab binds to the epidermal growth factor receptor (EGFr) on both normal and tumor cells. EGFr is over-expressed in many colorectal cancers. Cetuximab competitively inhibits the binding of epidermal growth factor (EGF) and TGF alpha, thereby reducing their effects on cell growth and metastatic spread.

Cetuximab Antibody, Abbexa, abx376582

Cetuximab Antibody is a rabbit polyclonal antibody for the detection of Cetuximab.

Anti-Cetuximab Polyclonal Antibody, AntibodySystem, PAB86901

Cetuximab Biosimilar - Research Grade, ichor.bio, ICH4004

Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Cetuximab.

Research Grade Cetuximab (HF004026), abinScience, HF004026

Cetuximab Biosimilar - GAALIE Research Grade, ichor.bio, ICH4004Fc

Detects human EGFR.

Cetuximab Vedotin Biosimilar - Research Grade, ichor.bio, ICH4004V

Anti-Cetuximab Neutralizing Antibody ELISA kit, ProteoGenix, KPTX305

Description of Anti-Cetuximab Neutralizing Antibody ELISA kit Introduction The Anti-Cetuximab Neutralizing Antibody ELISA kit is a powerful tool used in biomedical research for the detection and quantification of anti-cetuximab neutralizing antibodies. This kit is designed to provide a rapid and accurate method for measuring the levels of these antibodies in biological samples. In this article, we will discuss the structure, activity, and application of the Anti-Cetuximab Neutralizing Antibody ELISA kit. Structure of the Anti-Cetuximab Neutralizing Antibody ELISA kit The Anti-Cetuximab Neutralizing Antibody ELISA kit is composed of several components including a 96-well microplate, anti-cetuximab coated wells, cetuximab conjugate, sample diluent, wash buffer, and substrate solution. The microplate is coated with anti-cetuximab antibodies, which specifically bind to cetuximab present in the sample. The cetuximab conjugate is a labeled form of cetuximab that is used for detection. The sample diluent is used to dilute the biological sample, while the wash buffer is used to remove any unbound components. The substrate solution is added at the end of the assay and produces a color change that can be measured spectrophotometrically. Activity of the Anti-Cetuximab Neutralizing Antibody ELISA kit The Anti-Cetuximab Neutralizing Antibody ELISA kit utilizes the principle of enzyme-linked immunosorbent assay (ELISA) to detect and quantify anti-cetuximab neutralizing antibodies. The assay is based on the specific binding of anti-cetuximab antibodies to cetuximab present in the sample. The cetuximab conjugate then binds to the captured cetuximab, forming a sandwich complex. This complex is detected by the addition of the substrate solution, which produces a color change that is proportional to the amount of anti-cetuximab neutralizing antibodies present in the sample. The intensity of the color can be measured using a spectrophotometer, providing a quantitative measurement of the anti-cetuximab neutralizing antibody levels in the sample. Application of the Anti-Cetuximab Neutralizing Antibody ELISA kit The Anti-Cetuximab Neutralizing Antibody ELISA kit has a wide range of applications in both research and clinical settings. In research, this kit is used to study the immune response to cetuximab and its potential role in the development of resistance to cetuximab therapy. It can also be used to monitor the effectiveness of cetuximab treatment and to identify patients who may benefit from alternative therapies. In the clinical setting, the Anti-Cetuximab Neutralizing Antibody ELISA kit is used to guide treatment decisions for patients receiving cetuximab therapy. High levels of anti-cetuximab neutralizing antibodies have been associated with a reduced response to cetuximab treatment, making this kit a valuable tool for predicting treatment outcomes and identifying patients who may require alternative therapies. Conclusion In summary, the Anti-Cetuximab Neutralizing Antibody ELISA kit is a powerful tool for the detection and quantification of anti-cetuximab neutralizing antibodies. Its structure, activity, and application make it an essential tool for both research and clinical settings. This kit provides a rapid and accurate method for measuring anti-cetuximab neutralizing antibodies, allowing for better understanding of the immune response to cetuximab and improved treatment decisions for patients receiving cetuximab therapy.